3626 results for «301»
3626 results
TAVI pathways
21 Nov 2021 – From PCR London Valves 2021
In this PCR London Valves 2021 session, look at logistics and outcomes of TAVI during the COVID-19 pandemic, be presented with a simple risk-stratification tool based on a pre-procedural multimarker approach in TAVI, study duration of hospitalisation in patients with complicated transcatheter aortic valve implantation, and...
TAVI procedural improvements
21 Nov 2021 – From PCR London Valves 2021
Train on the cusp overlap method for self-expanding TAVR, get acquainted with override pacing to stabilize self-expandable TAVI valve, know more about atrioventricular conduction recovery and predictors of pacemakerr dependency after TAVI, among others, in this PCR London Valves 2021 session.
TAVI complications
21 Nov 2021 – From PCR London Valves 2021
Watch this session from PCR London Valves 2021 to appreciate the hybrid management of double aortic root rupture complicating TAVI, learn about an unexpected cause for complication during TAVR, investigate acute left main occlusion during TAVI, and much more!
The PASCAL IID Registry: A prospective registry for transcatheter edge-to-edge repair in prohibitive risk patients with degenerative mitral regurgitation and complex mitral valve anatomy
17 Sep 2022
Alex Sticchi provides his take on the PASCAL IID Registry and an initial comparison with the CLASP IID. The trial was presented by Jörg Hausleiter during TCT Congress 2022.
Author
Long-term beta-blocker treatment after acute myocardial infarction and preserved left ventricular ejection fraction: The REDUCE-AMI Trial
07 Apr 2024
REDUCE-AMI is a multicentre, registry-based, prospective open-label parallel-group randomised clinical trial evaluating the benefit of beta-blocker treatment in patients with acute MI and an ejection fraction >50% treated with a contemporary reperfusion strategy.
Nicola Ryan and Ali Nazmi Calik provide their take on the results which were presented...
Author
Author
SURTAVI: five-year results from a randomized trial of TAVR vs. SAVR in patients at intermediate surgical risk
07 Nov 2021
Although TAVI is an accepted alternative to surgery in patients with severe aortic stenosis who are at high surgical risk, less is known about long-term comparative outcomes among patients with aortic stenosis who are at intermediate surgical risk. P. Redaelli & M. Pighi review the SURTAVI trial...
Author
Author
